Our Mission

The National Bleeding Disorders Foundation (NBDF) Nebraska Chapter is dedicated to finding cures for inheritable blood disorders and addressing and preventing the complications of these disorders through research, education, and advocacy enabling people and families to thrive.

News Articles

Seawolf Therapeutics, a Pathway to Cures portfolio company, has announced a multi-target collaboration with Sanofi to develop new therapies for bleeding disorders and other indications. The agreement could provide Seawolf with up to $1.2 billion in milestone payments, plus tiered royalties on future product sales.

What’s Happening with Medicaid Work Requirements?

The National Bleeding Disorders Foundation (NBDF) has named Mark Brimble, PhD, the 2026 recipient of the NBDF-Sanofi Career Development Award (CDA). Dr. Brimble is an assistant professor of Pediatrics at Washington University School of Medicine in St. Louis. His project will study how the immune system responds to adeno-associated virus (AAV) gene therapy in people with hemophilia A and B.

Advertisers

Click to learn more

Resource Links

17330 W. Center Road
#110-325
Omaha, NE 68130

© National Bleeding Disorders Foundation 2026

Crafted by Firespring